Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for COGT

Stock Name	Cogent Biosciences Inc
Ticker	COGT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US19240Q2012

Show aggregate COGT holdings

News associated with COGT

Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $20.00: Cogent Biosciences (NASDAQ:COGT – Get Free Report) had its price target lifted by equities researchers at Guggenheim from $17.00 to $20.00 in a research note issued on Monday, MarketBeat.com reports. The firm currently has a “buy” rating on the technology company’s stock. Guggenheim’s price objective indicates a potential upside of 63.53% from the stock’s previous […] - 2025-08-27 02:08:48
Arizona State Retirement System Has $123,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT): Arizona State Retirement System grew its stake in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 18.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,567 shares of the technology company’s stock after purchasing an additional 3,142 shares during the […] - 2025-07-24 04:38:50
Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $22.00 at Citigroup: Cogent Biosciences (NASDAQ:COGT – Free Report) had its price objective boosted by Citigroup from $15.00 to $22.00 in a research note issued to investors on Friday morning,Benzinga reports. Citigroup currently has a buy rating on the technology company’s stock. Several other equities analysts have also recently commented on COGT. HC Wainwright boosted their target price […] - 2025-07-21 04:55:01
Analysts See 19% Gains Ahead For FHLC: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-14 09:54:06
Cogent Biosciences (NASDAQ:COGT) Trading 9% Higher Following Analyst Upgrade: Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report)’s share price traded up 9% during trading on Wednesday after JPMorgan Chase & Co. raised their price target on the stock from $25.00 to $29.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Cogent Biosciences traded as high as $10.12 and last traded […] - 2025-07-11 02:22:49
Cogent Biosciences (NASDAQ:COGT) Sees Large Volume Increase on Analyst Upgrade: Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) saw strong trading volume on Tuesday after HC Wainwright raised their price target on the stock from $12.00 to $22.00. HC Wainwright currently has a buy rating on the stock. 4,989,146 shares changed hands during mid-day trading, an increase of 236% from the previous session’s […] - 2025-07-10 02:52:43
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of “Moderate Buy” by Brokerages: Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation to the company. […] - 2025-07-08 05:26:50
Pre-Market Most Active for Jul 7, 2025 : TSLL, TSLA, TSLQ, COGT, BBAI, SQQQ, NVDA, HLN, CRCL, NIO, OSCR, QBTS: The NASDAQ 100 Pre-Market Indicator is down -99.52 to 22,767.45. The total Pre-Market volume is currently 171,325,842 shares traded.The following are the most active stocks for the pre-market session: Direxion Daily TSLA Bull 2X Shares (TSLL) is -1.4 at $10.13, with 43,244,717 s - 2025-07-07 09:29:58
Wedbush Reiterates “Neutral” Rating for Cogent Biosciences (NASDAQ:COGT): Cogent Biosciences (NASDAQ:COGT – Get Free Report)‘s stock had its “neutral” rating reissued by research analysts at Wedbush in a report issued on Monday,RTT News reports. They presently have a $10.00 target price on the technology company’s stock. Wedbush’s price objective would suggest a potential upside of 38.50% from the stock’s previous close. A number […] - 2025-07-02 02:56:48
Needham & Company LLC Reiterates Hold Rating for Cogent Biosciences (NASDAQ:COGT): Cogent Biosciences (NASDAQ:COGT – Get Free Report)‘s stock had its “hold” rating restated by equities research analysts at Needham & Company LLC in a note issued to investors on Tuesday,Benzinga reports. Several other research firms also recently commented on COGT. Scotiabank started coverage on Cogent Biosciences in a research note on Friday, March 7th. They […] - 2025-06-19 02:26:49
Cogent Biosciences, Inc. (NASDAQ:COGT) Stock Position Lessened by Wellington Management Group LLP: Wellington Management Group LLP decreased its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 16.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 284,850 shares of the technology company’s stock after selling 57,473 shares during the quarter. Wellington Management Group LLP’s holdings in Cogent Biosciences were worth $2,222,000 at […] - 2025-06-06 05:34:49
Nuveen Asset Management LLC Has $2.44 Million Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT): Nuveen Asset Management LLC lessened its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 0.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 313,099 shares of the technology company’s stock after selling 1,896 shares during the quarter. Nuveen Asset Management LLC’s holdings in Cogent Biosciences were worth $2,442,000 at […] - 2025-06-03 04:58:48
Cogent Biosciences, Inc. (NASDAQ:COGT) Position Increased by ProShare Advisors LLC: ProShare Advisors LLC increased its stake in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 30.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,074 shares of the technology company’s stock after purchasing an additional 7,267 shares during the period. […] - 2025-06-01 05:44:58
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Rating of “Moderate Buy” by Analysts: Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight brokerages that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation […] - 2025-05-26 05:29:06
HC Wainwright Has Lowered Expectations for Cogent Biosciences (NASDAQ:COGT) Stock Price: Cogent Biosciences (NASDAQ:COGT – Get Free Report) had its price target lowered by analysts at HC Wainwright from $14.00 to $12.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the technology company’s stock. HC Wainwright’s price target would indicate a potential upside of […] - 2025-05-22 03:12:43
30,300 Shares in Cogent Biosciences, Inc. (NASDAQ:COGT) Purchased by OMERS ADMINISTRATION Corp: OMERS ADMINISTRATION Corp purchased a new position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 30,300 shares of the technology company’s stock, valued at approximately $236,000. Several other hedge funds […] - 2025-05-21 05:26:52
D. E. Shaw & Co. Inc. Decreases Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT): D. E. Shaw & Co. Inc. lowered its position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 25.6% during the 4th quarter, HoldingsChannel reports. The fund owned 339,988 shares of the technology company’s stock after selling 117,240 shares during the period. D. E. Shaw & Co. Inc.’s holdings in Cogent Biosciences were worth $2,652,000 […] - 2025-05-20 04:57:06
Schonfeld Strategic Advisors LLC Takes $78,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT): Schonfeld Strategic Advisors LLC purchased a new stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 10,000 shares of the technology company’s stock, valued at approximately $78,000. A number of […] - 2025-05-15 05:40:52
Dimensional Fund Advisors LP Sells 48,771 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT): Dimensional Fund Advisors LP lessened its position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 6.2% in the fourth quarter, HoldingsChannel reports. The firm owned 743,652 shares of the technology company’s stock after selling 48,771 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Cogent Biosciences were worth $5,800,000 as of its most […] - 2025-05-12 04:50:50
Cogent Biosciences Sees Unusually High Options Volume (NASDAQ:COGT): Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) was the recipient of unusually large options trading activity on Thursday. Investors purchased 20,016 call options on the company. This is an increase of 5,019% compared to the typical volume of 391 call options. Cogent Biosciences Stock Up 8.1 % Shares of NASDAQ:COGT opened at $5.63 on […] - 2025-05-02 02:09:01
Legal & General Group Plc Sells 2,304 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT): Legal & General Group Plc cut its position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 3.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 69,541 shares of the technology company’s stock after selling 2,304 shares during […] - 2025-04-30 04:46:50
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.43 Consensus Target Price from Analysts: Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight ratings firms that are covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation […] - 2025-04-29 04:41:03
Alliancebernstein L.P. Buys 382,882 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT): Alliancebernstein L.P. lifted its position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 466.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 464,942 shares of the technology company’s stock after acquiring an additional 382,882 shares during the quarter. Alliancebernstein […] - 2025-04-15 04:52:58
KLP Kapitalforvaltning AS Acquires Shares of 11,300 Cogent Biosciences, Inc. (NASDAQ:COGT): KLP Kapitalforvaltning AS bought a new stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 11,300 shares of the technology company’s stock, valued at approximately $88,000. Other hedge funds and other institutional investors […] - 2025-04-11 04:44:59
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives Consensus Rating of “Moderate Buy” from Analysts: Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have received an average rating of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy […] - 2025-04-04 04:57:00
Cogent Biosciences, Inc. (NASDAQ:COGT) Stock Holdings Boosted by Intech Investment Management LLC: Intech Investment Management LLC boosted its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 99.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 56,657 shares of the technology company’s stock after buying an additional 28,233 shares during the quarter. […] - 2025-03-25 06:31:05
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by AlphaQuest LLC: AlphaQuest LLC reduced its stake in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 67.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 8,012 shares of the technology company’s stock after selling 16,970 shares during the quarter. AlphaQuest LLC’s holdings in Cogent Biosciences were […] - 2025-03-20 06:13:09
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Rating of “Moderate Buy” by Analysts: Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target […] - 2025-03-10 05:10:47
Cogent Biosciences (NASDAQ:COGT) Now Covered by Scotiabank: Scotiabank assumed coverage on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a report issued on Friday morning, Marketbeat Ratings reports. The brokerage issued a sector outperform rating and a $17.00 price objective on the technology company’s stock. COGT has been the subject of several other research reports. Wedbush reaffirmed a “neutral” rating and […] - 2025-03-10 03:50:48
New York State Common Retirement Fund Acquires 2,200 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT): New York State Common Retirement Fund boosted its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 10.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,102 shares of the technology company’s stock after purchasing an additional 2,200 shares […] - 2025-03-06 08:19:23

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) COGT holdings

Date	Number of COGT Shares Held	Base Market Value of COGT Shares	Local Market Value of COGT Shares	Change in COGT Shares Held	Change in COGT Base Value	Current Price per COGT Share Held	Previous Price per COGT Share Held
2025-11-11 (Tuesday)	89,625	USD 2,995,268	USD 2,995,268	230	USD 93,506	USD 33.42	USD 32.46
2025-11-10 (Monday)	89,395	USD 2,901,762	USD 2,901,762	0	USD 1,576,928	USD 32.46	USD 14.82
2025-11-07 (Friday)	89,395	USD 1,324,834	USD 1,324,834	0	USD 8,940	USD 14.82	USD 14.72
2025-11-06 (Thursday)	89,395	USD 1,315,894	USD 1,315,894	230	USD 30,135	USD 14.72	USD 14.42
2025-11-05 (Wednesday)	89,165	USD 1,285,759	USD 1,285,759	0	USD 25,858	USD 14.42	USD 14.13
2025-11-04 (Tuesday)	89,165	USD 1,259,901	USD 1,259,901	231	USD -118,576	USD 14.13	USD 15.5
2025-11-03 (Monday)	88,934	USD 1,378,477	USD 1,378,477	0	USD -71,147	USD 15.5	USD 16.3
2025-10-31 (Friday)	88,934	USD 1,449,624	USD 1,449,624	0	USD 8,004	USD 16.3	USD 16.21
2025-10-30 (Thursday)	88,934	USD 1,441,620	USD 1,441,620	1,155	USD 37,156	USD 16.21	USD 16
2025-10-29 (Wednesday)	87,779	USD 1,404,464	USD 1,404,464	462	USD -467	USD 16	USD 16.09
2025-10-28 (Tuesday)	87,317	USD 1,404,931	USD 1,404,931	0	USD -9,604	USD 16.09	USD 16.2
2025-10-27 (Monday)	87,317	USD 1,414,535	USD 1,414,535	0	USD 93,429	USD 16.2	USD 15.13

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of COGT by Blackrock for IE00BDZVHG35

Show aggregate share trades of COGT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-11 BUY 230 34.500 28.870 29.433 USD 6,770 8.85
2025-11-06 BUY 230 15.085 14.210 14.298 USD 3,288 8.65
2025-11-04 BUY 231 15.870 13.980 14.169 USD 3,273 8.59
2025-10-30 BUY 1,155 16.500 15.970 16.023 USD 18,507 8.47
2025-10-29 BUY 462 16.000 16.416 16.375 USD 7,565 8.43
2025-10-22 SELL -920 14.850 15.820 15.723 USD -14,465 8.22 Loss of -6,900 on sale
2025-10-20 BUY 460 16.220 17.000 16.922 USD 7,784 8.13
2025-10-17 BUY 1,149 16.390 16.500 16.489 USD 18,946 8.08
2025-10-15 BUY 1,832 16.570 16.580 16.579 USD 30,373 8.03
2025-10-03 BUY 1,617 15.760 16.010 15.985 USD 25,848 7.94
2025-10-02 BUY 231 14.750 14.770 14.768 USD 3,411 7.90
2025-09-30 BUY 462 14.360 14.535 14.517 USD 6,707 7.82
2025-09-26 BUY 462 14.160 14.180 14.178 USD 6,550 7.75
2025-09-25 BUY 462 13.290 13.500 13.479 USD 6,227 7.71
2025-09-18 BUY 200 12.720 12.750 12.747 USD 2,549 7.68
2025-09-17 BUY 603 12.360 12.860 12.810 USD 7,724 7.65
2025-07-17 SELL -398 12.200 12.515 12.484 USD -4,968 7.53 Loss of -1,972 on sale
2025-07-11 SELL -1,600 10.980 11.325 11.290 USD -18,065 7.43 Loss of -6,181 on sale
2025-07-02 BUY 11,055 7.410 7.680 7.653 USD 84,604 7.38
2025-06-25 BUY 400 7.070 7.310 7.286 USD 2,914 7.39
2025-06-20 BUY 3,473 7.230 7.450 7.428 USD 25,797 7.39
2025-06-11 BUY 380 7.260 7.610 7.575 USD 2,879 7.40
2025-06-10 BUY 380 7.420 7.640 7.618 USD 2,895 7.40
2025-06-04 SELL -191 5.640 5.800 5.784 USD -1,105 7.43 Profit of 314 on sale
2025-04-23 BUY 191 4.470 4.640 4.623 USD 883 8.16
2025-04-10 SELL -1,528 4.020 4.330 4.299 USD -6,569 8.54 Profit of 6,479 on sale
2025-04-08 SELL -190 4.140 5.110 5.013 USD -952 8.64 Profit of 688 on sale
2025-04-07 SELL -190 4.580 4.860 4.832 USD -918 8.68 Profit of 732 on sale
2025-04-04 SELL -955 4.770 5.230 5.184 USD -4,951 8.73 Profit of 3,386 on sale
2025-04-01 BUY 780 5.790 6.015 5.992 USD 4,674 8.80
2025-03-31 SELL -573 5.990 6.440 6.395 USD -3,664 8.84 Profit of 1,398 on sale
2025-03-21 BUY 4,080 7.160 7.332 7.315 USD 29,844 8.99
2025-03-14 SELL -2,848 7.140 7.500 7.464 USD -21,257 9.11 Profit of 4,697 on sale
2025-03-07 SELL -356 7.010 7.480 7.433 USD -2,646 9.26 Profit of 650 on sale
2025-03-04 SELL -178 7.170 7.280 7.269 USD -1,294 9.35 Profit of 370 on sale
2025-02-25 BUY 356 6.990 7.470 7.422 USD 2,642 9.54
2025-02-19 SELL -177 8.080 8.160 8.152 USD -1,443 9.67 Profit of 268 on sale
2025-02-13 BUY 528 8.180 8.250 8.243 USD 4,352 9.79
2025-02-12 BUY 176 8.140 8.342 8.322 USD 1,465 9.83
2025-02-11 BUY 704 8.420 8.755 8.722 USD 6,140 9.86
2024-12-30 SELL -5,567 7.710 7.750 7.746 USD -43,122 10.31 Profit of 14,254 on sale
2024-11-18 SELL -2,838 8.990 9.075 9.066 USD -25,731 11.40 Profit of 6,635 on sale
2024-11-08 SELL -190 10.210 10.395 10.377 USD -1,972 11.56 Profit of 225 on sale
2024-10-21 SELL -190 11.860 12.038 12.020 USD -2,284 0.00 Loss of -2,284 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-11	BUY	230	34.500	28.870	29.433	USD 6,770	8.85
2025-11-06	BUY	230	15.085	14.210	14.298	USD 3,288	8.65
2025-11-04	BUY	231	15.870	13.980	14.169	USD 3,273	8.59
2025-10-30	BUY	1,155	16.500	15.970	16.023	USD 18,507	8.47
2025-10-29	BUY	462	16.000	16.416	16.375	USD 7,565	8.43
2025-10-22	SELL	-920	14.850	15.820	15.723	USD -14,465	8.22 Loss of -6,900 on sale
2025-10-20	BUY	460	16.220	17.000	16.922	USD 7,784	8.13
2025-10-17	BUY	1,149	16.390	16.500	16.489	USD 18,946	8.08
2025-10-15	BUY	1,832	16.570	16.580	16.579	USD 30,373	8.03
2025-10-03	BUY	1,617	15.760	16.010	15.985	USD 25,848	7.94
2025-10-02	BUY	231	14.750	14.770	14.768	USD 3,411	7.90
2025-09-30	BUY	462	14.360	14.535	14.517	USD 6,707	7.82
2025-09-26	BUY	462	14.160	14.180	14.178	USD 6,550	7.75
2025-09-25	BUY	462	13.290	13.500	13.479	USD 6,227	7.71
2025-09-18	BUY	200	12.720	12.750	12.747	USD 2,549	7.68
2025-09-17	BUY	603	12.360	12.860	12.810	USD 7,724	7.65
2025-07-17	SELL	-398	12.200	12.515	12.484	USD -4,968	7.53 Loss of -1,972 on sale
2025-07-11	SELL	-1,600	10.980	11.325	11.290	USD -18,065	7.43 Loss of -6,181 on sale
2025-07-02	BUY	11,055	7.410	7.680	7.653	USD 84,604	7.38
2025-06-25	BUY	400	7.070	7.310	7.286	USD 2,914	7.39
2025-06-20	BUY	3,473	7.230	7.450	7.428	USD 25,797	7.39
2025-06-11	BUY	380	7.260	7.610	7.575	USD 2,879	7.40
2025-06-10	BUY	380	7.420	7.640	7.618	USD 2,895	7.40
2025-06-04	SELL	-191	5.640	5.800	5.784	USD -1,105	7.43 Profit of 314 on sale
2025-04-23	BUY	191	4.470	4.640	4.623	USD 883	8.16
2025-04-10	SELL	-1,528	4.020	4.330	4.299	USD -6,569	8.54 Profit of 6,479 on sale
2025-04-08	SELL	-190	4.140	5.110	5.013	USD -952	8.64 Profit of 688 on sale
2025-04-07	SELL	-190	4.580	4.860	4.832	USD -918	8.68 Profit of 732 on sale
2025-04-04	SELL	-955	4.770	5.230	5.184	USD -4,951	8.73 Profit of 3,386 on sale
2025-04-01	BUY	780	5.790	6.015	5.992	USD 4,674	8.80
2025-03-31	SELL	-573	5.990	6.440	6.395	USD -3,664	8.84 Profit of 1,398 on sale
2025-03-21	BUY	4,080	7.160	7.332	7.315	USD 29,844	8.99
2025-03-14	SELL	-2,848	7.140	7.500	7.464	USD -21,257	9.11 Profit of 4,697 on sale
2025-03-07	SELL	-356	7.010	7.480	7.433	USD -2,646	9.26 Profit of 650 on sale
2025-03-04	SELL	-178	7.170	7.280	7.269	USD -1,294	9.35 Profit of 370 on sale
2025-02-25	BUY	356	6.990	7.470	7.422	USD 2,642	9.54
2025-02-19	SELL	-177	8.080	8.160	8.152	USD -1,443	9.67 Profit of 268 on sale
2025-02-13	BUY	528	8.180	8.250	8.243	USD 4,352	9.79
2025-02-12	BUY	176	8.140	8.342	8.322	USD 1,465	9.83
2025-02-11	BUY	704	8.420	8.755	8.722	USD 6,140	9.86
2024-12-30	SELL	-5,567	7.710	7.750	7.746	USD -43,122	10.31 Profit of 14,254 on sale
2024-11-18	SELL	-2,838	8.990	9.075	9.066	USD -25,731	11.40 Profit of 6,635 on sale
2024-11-08	SELL	-190	10.210	10.395	10.377	USD -1,972	11.56 Profit of 225 on sale
2024-10-21	SELL	-190	11.860	12.038	12.020	USD -2,284	0.00 Loss of -2,284 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of COGT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	178,710	0	374,744	47.7%
2025-09-18	144,303	0	492,031	29.3%
2025-09-17	204,285	1	726,102	28.1%
2025-09-16	150,691	0	462,672	32.6%
2025-09-15	123,353	9,124	300,516	41.0%
2025-09-12	450,700	3,878	931,716	48.4%
2025-09-11	772,950	0	1,176,197	65.7%
2025-09-10	261,353	0	456,012	57.3%
2025-09-09	511,477	0	964,761	53.0%
2025-09-08	209,439	0	470,138	44.5%
2025-09-05	465,988	0	673,243	69.2%
2025-09-04	181,762	0	430,780	42.2%
2025-09-03	473,022	0	1,810,674	26.1%
2025-09-02	176,868	2,239	441,974	40.0%
2025-08-29	87,706	0	418,644	21.0%
2025-08-28	148,192	0	494,102	30.0%
2025-08-27	139,566	0	227,000	61.5%
2025-08-26	98,499	0	159,127	61.9%
2025-08-25	116,374	55	228,986	50.8%
2025-08-22	116,232	0	299,050	38.9%
2025-08-21	43,039	100	186,987	23.0%
2025-08-20	128,443	146	178,217	72.1%
2025-08-19	156,176	100	290,001	53.9%
2025-08-18	350,319	0	521,654	67.2%
2025-08-15	150,305	0	224,409	67.0%
2025-08-14	177,013	0	478,177	37.0%
2025-08-13	221,392	123	621,407	35.6%
2025-08-12	173,664	0	323,917	53.6%
2025-08-11	112,167	0	242,980	46.2%
2025-08-08	214,099	0	398,838	53.7%
2025-08-07	286,806	0	721,705	39.7%
2025-08-06	199,883	19,134	622,043	32.1%
2025-08-05	359,248	0	998,340	36.0%
2025-08-04	172,949	11,386	344,270	50.2%
2025-08-01	229,951	794	427,500	53.8%
2025-07-31	232,840	127	882,862	26.4%
2025-07-30	364,907	5,808	619,895	58.9%
2025-07-29	136,763	40	415,525	32.9%
2025-07-28	152,949	0	381,681	40.1%
2025-07-25	297,157	0	584,570	50.8%
2025-07-24	193,704	400	733,305	26.4%
2025-07-23	452,121	619	1,363,605	33.2%
2025-07-22	658,945	0	1,703,582	38.7%
2025-07-21	363,053	62	886,644	40.9%
2025-07-18	475,602	5,000	1,732,913	27.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE